Challenge of the Week / Knee / 11.22.19

When compared with bupivicaine HCl for pain management following total knee arthroplasty, periarticular injection of liposomal bupivicaine offers which of the following?
  • Lower visual analog scale (VAS) in-hospital pain scores
  • There is no data to suggest lower pain scores in high quality studies.

  • Improved Knee Society scores at 6 weeks
  • There is no data to suggest improved functional outcomes.

  • Reduced opioid consumption
  • There is no data to suggest reduced opioid consumption.

  • No difference in pain control, function, or opioid consumption
  • Several randomized controlled trials have found no benefit to liposomal bupivicaine.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.